MedTrace Logo

QOL After SURGERY and ADJUVANT Treatment

NCT06115239 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-05-07

No results posted yet for this study

Summary

The goal of this prospective, observational study is to measure and analyze the effect of adjuvant treatment over the quality of life and recovery of patients undergoing pulmonary resection because of non-small cells lung cancer using the EORTC-LC29 questionnaire. The main question it aims to answer is:

Whether adjuvant systemic treatment affect or not the postoperative QOL of a NSCLC patient that underwent lung resection

Participants will fulfill two questionnaires (EORTC-LC29 and Hospital Anxiety and Depression Scale) in different stages of their treatment.

Conditions

  • Carcinoma, Non-Small-Cell Lung
  • Quality of Life

Interventions

OTHER

Questionnaires

The patients will fulfill the EORTC-LC29 and HADS questionnaires in 5 different moments.

Sponsors & Collaborators

  • University of Salamanca

    lead OTHER

Principal Investigators

  • Pablo Fernández Salvador, Nurse · University of Salamanca

  • Nuria M Novoa Valentín, MD, PhD · University of Salamanca

  • Marta G Fuentes Gago, MD, PhD · University of Salamanca

  • María B García Cenador, MD, PhD · University of Salamanca

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-11-30
Completion
2026-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115239 on ClinicalTrials.gov